Yesterday, October 22, 2026, Spago Nanomedical AB (publ) (the "Company") issued a press release stating that the Company's board of directors had resolved to apply for the removal of the Company's shares from trading on Nasdaq First North Growth Market, conditional upon approval by a general meeting of the Company's shareholders.
According to item 6.3.1 (d) of the Nasdaq First North Growth Market Rulebook, an issuer's financial instruments may be given observation status if the issuer has disclosed its intention to have its financial instruments removed from trading on Nasdaq First North Growth Market.
With reference to the above, Nasdaq Stockholm AB decides that the Company's shares shall be given observation status.
| Company name: | Spago Nanomedical AB (publ) |
| Short name: | SPAGO |
| ISIN code: | SE0004899474 |
For further information about this exchange notice please contact Enforcement & Investigations, telephone +46 8 405 70 50.
